|
Name |
cyperusol C
|
Molecular Formula | C15H26O2 | |
IUPAC Name* |
(1R,4R,4aR,6R,8aR)-4,8a-dimethyl-6-prop-1-en-2-yl-1,2,3,4a,5,6,7,8-octahydronaphthalene-1,4-diol
|
|
SMILES |
CC(=C)[C@@H]1CC[C@]2([C@@H](CC[C@@]([C@@H]2C1)(C)O)O)C
|
|
InChI |
InChI=1S/C15H26O2/c1-10(2)11-5-7-14(3)12(9-11)15(4,17)8-6-13(14)16/h11-13,16-17H,1,5-9H2,2-4H3/t11-,12-,13-,14-,15-/m1/s1
|
|
InChIKey |
LGKGTMWCBFNQHP-KJWHEZOQSA-N
|
|
Synonyms |
cyperusol C; CHEBI:69847; CHEMBL465340; SCHEMBL19714786; (1R,4R,4aR,6R,8aR)-4,8a-dimethyl-6-prop-1-en-2-yl-1,2,3,4a,5,6,7,8-octahydronaphthalene-1,4-diol; Q27138186
|
|
CAS | NA | |
PubChem CID | 11230158 | |
ChEMBL ID | CHEMBL465340 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 238.37 | ALogp: | 3.1 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 40.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 17 | QED Weighted: | 0.684 |
Caco-2 Permeability: | -4.641 | MDCK Permeability: | 0.00002750 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.009 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.049 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.122 | Plasma Protein Binding (PPB): | 76.20% |
Volume Distribution (VD): | 1.31 | Fu: | 26.29% |
CYP1A2-inhibitor: | 0.032 | CYP1A2-substrate: | 0.477 |
CYP2C19-inhibitor: | 0.03 | CYP2C19-substrate: | 0.851 |
CYP2C9-inhibitor: | 0.048 | CYP2C9-substrate: | 0.761 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.781 |
CYP3A4-inhibitor: | 0.047 | CYP3A4-substrate: | 0.213 |
Clearance (CL): | 5.393 | Half-life (T1/2): | 0.602 |
hERG Blockers: | 0.029 | Human Hepatotoxicity (H-HT): | 0.057 |
Drug-inuced Liver Injury (DILI): | 0.033 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.081 | Maximum Recommended Daily Dose: | 0.845 |
Skin Sensitization: | 0.396 | Carcinogencity: | 0.027 |
Eye Corrosion: | 0.944 | Eye Irritation: | 0.988 |
Respiratory Toxicity: | 0.82 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002051 | 0.607 | D00VZZ | 0.313 | ||||
ENC005066 | 0.607 | D06XMU | 0.300 | ||||
ENC005497 | 0.607 | D04DJN | 0.300 | ||||
ENC000332 | 0.410 | D04VIS | 0.299 | ||||
ENC001836 | 0.410 | D0B4RU | 0.298 | ||||
ENC002073 | 0.410 | D03XOC | 0.287 | ||||
ENC001814 | 0.396 | D07QKN | 0.283 | ||||
ENC000411 | 0.396 | D0L2LS | 0.279 | ||||
ENC001079 | 0.387 | D0G3SH | 0.271 | ||||
ENC001893 | 0.375 | D03ZTE | 0.271 |